Study S002695

Investigating the Effectiveness of Novel Amino Acid-enriched Supplement Beverages to Determine Post-ingestion Glycemia, Insulinemia, Aminoacidemia, and Whole-body Protein Synthesis Rates in Adults Prescribed GLP-1 RA Drugs

ClinicalTrials.gov record

Registration

Registration: NCT07595575
Acronym: Leuvate001
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: QUADRUPLE
Status: NOT_YET_RECRUITING
Enrollment: 8
Start: 2026-06-01
Primary completion: 2026-08-01
Lead sponsor: Nutraceutical Innovations LLC
Conditions: The Whole-body Protein Synthesis Response to Protein With Amino Acid or Amino Acids
Interventions: DIETARY_SUPPLEMENT:GLP-1
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Whole-body protein synthesis [5 hours following consumption.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.